http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111500542-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-24221 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-24021 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0693 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 |
| filingDate | 2020-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111500542-B |
| titleOfInvention | Bovine testicular supporting cell carcinoma cell and application thereof in separation and culture of poxvirus |
| abstract | The invention discloses a bovine testicular supporting cell carcinoma cell and application thereof in separation and culture of poxvirus. The bovine testicular supporting cell carcinoma cell is named as a bovine testicular supporting cell carcinoma cell BTSCC, and the preservation number of the bovine testicular supporting cell carcinoma cell BTSCC is CCTCC NO: C201931. furthermore, the invention also provides application of the bovine testicular supporting cell cancer cell in separation and culture of poxvirus such as ORFV, GTPV and the like. The cell is sensitive to ORFV and GTPV cell virus, can efficiently proliferate ORFV and GTPV virus, and can ensure the uniformity and stability of the virus. The virus titer proliferated by using the cell is equivalent to that of a neonatal bovine testis supporting cell (NBSC), and the neonatal bovine testis supporting cell has the advantages of high growth speed and high seed sorting rate, and can grow under the condition of low serum culture. By using the cell to separate and culture the ORFV and GTPV virus, the test efficiency can be improved, the test cost can be reduced, and the stability of the quality of the vaccine prepared by using the cell can be ensured. The invention provides a new technical means for culturing the poxvirus and producing the vaccine in large scale. |
| priorityDate | 2020-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 174.